Catalyst Wire Dossier Catalyst Wire Dossier

Infanrix IPV+Hib (Penta)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Infanrix IPV+Hib (Penta), covering 2015-01-07 to 2015-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]

See pricing